Compound ID | 884
Class: Quinoline-indole
| Spectrum of activity: | Gram-negative |
| Details of activity: | Lysis followed bacteria death, thought to be related to membrane damage |
| Institute where first reported: | Sepracor (Sunovion Pharmaceuticals, Inc) |
| Year first mentioned: | 2000 |
| Highest developmental phase: | Preclinical |
| Development status: | Inactive |
| Chemical structure(s): | |||||||||||
|
|